COVID-19


Get the latest Emory news and announcements about COVID-19 through Emory Forward. 

Go to Emory Forward

ORA COVID-19 Updates

Important point on medications from Governor Kemp's briefing on March 23, 2020, signs Executive Order

All licensed Georgia pharmacists are now permitted to dispense a ninety-day supply of a prescription drug if a patient has no remaining refills and the pharmacist cannot get in contact with the prescribing provider. Pharmacists may also dispense early refills for prescription drugs. However, these authorizations do not apply to Schedule II controlled substances.


Emory University

Centers for Disease Control and Prevention

Journal of the American Medical Association

National Institute of Environmental Health Sciences

World Health Organization

Other Resources

Please check back for updates.

Thursdays at Three (T@3)

Thursdays at Three (T@3) (previously known as Fridays at Four) is a bi-monthly virtual research webinar series to keep faculty engaged and updated on research topics and operations.


Nell Hodgson Woodruff School of Nursing

Office for Clinical Research

Office of the Senior Vice President for Research

Rollins School of Public Health


Georgia Clinical & Translational Science Alliance

National Council of University Research Administrators

National Institutes of Health

The Office of Research Administration has been compiling as much information as possible on impacts to sponsored research from COVID-19. ORA will continue to update this page with information as we receive it from each agency. In addition, we have compiled a list of Frequently Asked Questions (PDF) related to sponsored research. As we receive more questions, and answers, we will continue to update the list.

Agency for Healthcare Research and Quality (AHRQ)

Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations

American Cancer Society

COVID-19 and 2020 ACS Grants

American Heart Association

Resource from AHA: Interim Guidance on Extensions for AHA Instructor & Provider Cards during COVID-19 Outbreak (PDF)

Centers for Disease Control and Prevention

Resources from the CDC include:

Council on Governmental Relations

Department of Defense

Hanover Research

Grants Calendar: COVID-19 Funding

Health Resources & Services Administration (HRSA)

Novel Coronavirus (COVID-19) Frequently Asked Questions

National Cancer Institute

National Institutes of Health

NIH Website: Coronavirus Disease 2019 (COVID-19)

Resources from NIH include:

National Science Foundation

The National Science Foundation has developed a new website for the research community with their detailed guidance on COVID-19, including Frequently Asked Questions. Of interest, NSF has confirmed that they will continue to accept proposal submissions and adhere to currently stated deadlines.

NSF Implementation of OMB Memorandum M-20-17, entitled, "Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations" dated March 19, 2020

Sponsor-specific Information from Additional Sponsors

Ex Libris Pivot & Research Professional

Select Research Funding Opportunities related to Coronavirus (COVID-19) (PDF)

Georgia CTSA Weekly eRoundup

Funding & Related Information

GrantForward

LifeArc

UK-based Nonprofit Funding

National Center for Advancing Translational Sciences

National Institute for Health Research

National Institute of Allergy and Infectious Diseases

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

National Institute of Biomedical Imaging and Bioengineering

Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing

National Institute of General Medical Sciences

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2

National Institute on Drug Abuse

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

National Institutes of Health

National Institute on Aging

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

National Institute of Mental Health

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

National Institute on Minority Health and Health Disparities

Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

National Science Foundation

Office of Behavioral and Social Sciences Research

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

Patient-Centered Outcomes Research Institute

Phased Large Awards for Comparative Effectiveness Research – Cycle 3 2020

System for Award Management

University of Texas at Austin

Open Call Grant and Award Opportunities

Amazon Web Services for Coronavirus Research

Emory’s Amazon Web Services (AWS) partners informed OIT that the AWS Disaster Response Program is coordinating across AWS to identify organizations, customers, and partners active in gene sequencing, diagnostics, epidemic modeling, vaccine development, treatment development, and monitoring & evaluation for Novel Coronavirus (nCoV) for immediate and long-term engagement.

In many cases, they will provide promotional AWS utilization credits for Cloud-based research toward the Coronavirus and they are available to help submit cases for credits. OIt is available to help researchers onboard and navigate AWS in the Emory Cloud computing environment.

If anyone is interested, please contact OIT at aws.help@emory.edu.

Digital Science Dimensions

Dimensions is updated once every 24 hours, so the latest research can be viewed alongside existing information. With its range of research outputs including datasets and clinical trials, both of which are just as important as journal articles in the face of a potential pandemic, Dimensions is a one-stop shop for all COVID-19 related information. More information from Digital-Science.com

Extreme Science and Engineering Discovery Environment

XSEDE’s HPC-COVID19 Consortium, charged with meeting the high-performance computing needs of COVID19-related data analytics, simulation, bioinformatics, drug design and repurposing, and other applications.

Nature Research Microbiology Community

A weekly review of the latest SARS-CoV-2 and COVID-19 literature. More information on the Nature Microbiology Community.

Emory University - Human Resources

National Educational Services

Security Awareness

Quick Guide

Important point on medications from Governor Kemp's briefing on March 23, 2020, signs Executive Order

All licensed Georgia pharmacists are now permitted to dispense a ninety-day supply of a prescription drug if a patient has no remaining refills and the pharmacist cannot get in contact with the prescribing provider. Pharmacists may also dispense early refills for prescription drugs. However, these authorizations do not apply to Schedule II controlled substances.

Coronavirus Business Continuity Policy

As it pertains to the Business Continuity Policy, please refer to the email sent by Dr. Robert Nobles on March 19th.